EORTC/X
Nov 2, 2024, 19:35
EORTC successfully completed the prospective recruitment for the SPECTA IMMUcan cohort with 1,472 patients in total
EORTC shared a post on LinkedIn:
“We are thrilled to announce that as of 30 October, we have successfully completed the prospective recruitment for the EORTC SPECTA IMMUcan cohort with 1,472 patients in total.
This incredible journey began five years ago with the enrollment of our first patient in June 2019.
Thanks to external collaborations, the total number of patients analysed in IMMUcan will reach 2,650, all of whom will undergo comprehensive molecular and cellular profiling.
The analysis of all the generated data will continue next year. Stay tuned for more updates.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 23, 2024, 06:21
Dec 23, 2024, 06:08
Dec 23, 2024, 06:05
Dec 23, 2024, 06:00
Dec 23, 2024, 05:43
Dec 22, 2024, 18:02
Dec 22, 2024, 17:54